Trade Summary

3 days ago, Hoffman Michael B, serving as Dir at Annovis Bio, Inc. (ANVS), purchased 713,800 shares at $2.10 per share, for a total transaction value of $1,498,980.00. Following this transaction, Hoffman Michael B now holds 3,511,896 shares of ANVS.

This purchase represents a 26.00% increase in Hoffman Michael B's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, April 2, 2026 and publicly disclosed via SEC Form 4 filing on Friday, April 3, 2026, 1 day after the trade was made.

Annovis Bio, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.